Abstract:Normal tissue tolerance remains the major limiting factor to dose escalation and its greater therapeutic potential. Previous studies have shown that DNA-activated Protein Kinase catalytic peptide (DNAPK) is critical to non-homologous end joining repair, a pathway triggered in response to DNA double strand breaks. Reductions in DNAPK expression typically result in substantial radiation sensitivity. We have previously reported aptamer-targeted siRNA-mediated reductions in DNAPK resulting in tumor specific radiation sensitization. Here we report siRNAs specific for DNAPK conjugated to a urea-based affinity agent that targets the prostate-specific membrane antigen (PSMA), an enzyme overexpressed on prostate cancer cells. The overall construct involves two levels of targeting, first to prostate cancer by virtue of PSMA expression and second to DNAPK mRNA expression through a specific siRNA (21mer or 27mer). We hypothesize that our agents will selectively recognize PSMA-expressing cells, become internalized and processed, yielding therapeutically-relevant reductions in DNAPK expression. A PSMA-targeted Glu-Lys urea moiety was conjugated to variably modified DNAPK21, 5’NH2-modified DNAPK27 and 3’NH2-modified DNAPK27 siRNA by amide bond formation from the corresponding active ester. Conjugations used at least a 5:1 ratio of Glu-Lys urea to siRNA. Lipofectamine transfection of the conjugates into LNCaP cells was performed to investigate cellular processing of the siRNA. Treatment without lipofectamine was used to determine if conjugates could independently bind PSMA, internalize and reduce DNAPK mRNA. mRNA levels were determined by RT-PCR. Preliminary results of lipofectamine transfected urea-siRNA conjugates reveal up to 90% knockdown of DNAPK mRNA expression relative to control. Direct treatment of the LNCaP cancer cell line with the urea-5’DNAPK27 conjugate resulted in a 53% DNAPK mRNA knockdown (P = 0.068), while the urea-3’DNAPK27 conjugate demonstrated a 37.6% DNAPK mRNA knockdown (P = 0.025). The urea-DNAPK21 conjugate yielded 43% DNAPK mRNA knockdown (P<0.01). Cancer cell specific radiosensitization promises to enable tumor control while reducing radiation-induced side effects. We provide results supporting that PSMA-targeted DNAPK siRNA conjugates can be constructed, delivered and successfully targeted to prostate cancer, resulting in reductions in target mRNA in a fashion that may lead to selective prostate cancer radiosensitization.

Silencing Mannosylphospho Dolichol Synthase with Shrna Impacts Differentiation of Capillary Endothelial Cells

Neuropilin-2–Mediated Tumor Growth and Angiogenesis in Pancreatic Adenocarcinoma

RETRACTED ARTICLE: Hsa_circ_0008360 Sponges Mir-186-5p to Target CCND2 to Modulate High Glucose-Induced Vascular Endothelial Dysfunction

Long-term results of aortic root repair using the reimplantation technique.

A Novel Identified Circular RNA, mmu_mmu_circRNA_0000309, Involves in Germacrone-Mediated Improvement of Diabetic Nephropathy Through Regulating Ferroptosis by Targeting miR-188-3p/GPX4 Signaling Axis

Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer Cells

Psma-Targeted Low Molecular Weight Urea-Sirna Conjugates For Targeted Knockdown Of Dna-Pk And Radiosensitization Of Prostate Cancer Cell Lines

Tunicamycin interferes with WNT signaling and inhibits angiogenesis

RNA interference-mediated silencing of ppGalNAc-T1 and ppGalNAc-T2 inhibits invasion and increases chemosensitivity potentially by reducing terminal α2,3 sialylation and MMP14 expression in triple‑negative breast cancer cells

Proteomics Identifies Thymidine Phosphorylase As A Key Regulator Of The Angiogenic Potential Of Colony Forming Units And Endothelial Progenitor Cell Cultures

High Mannose N-Glycans Promote Migration of Bone-Marrow-Derived Mesenchymal Stromal Cells

Down Syndrome Candidate Region 1 Isoform 1L regulated tumor growth by targeting both angiogenesis and tumor cells

The role of MDM2 in angiogenesis: implications for endothelial tip cell formation

Chemical inhibition of oxygen-sensing prolyl hydroxylases impairs angiogenic competence of human vascular endothelium through metabolic reprogramming

High Glucose Treatment Limits Drosha Protein Expression and Alters AngiomiR Maturation in Microvascular Primary Endothelial Cells via an Mdm2-dependent Mechanism

Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases

Should all pregnant patients be offered prenatal diagnosis regardless of age?

Penetration and Silencing Activity of VEGF Dicer Substrate siRNA Vectorized by Chitosan Nanoparticles in Monolayer Culture and a Solid Tumor Model In Vitro for Potential Application in Tumor Therapy

Ddah1 Deficiency Attenuates Endothelial Cell Cycle Progression and Angiogenesis

Diabetic kidney disease induces transcriptome alterations associated with angiogenesis activity in human mesenchymal stromal cells

TMET-01. THERAPEUTIC TARGETING OF CROSSTALK BETWEEN MITOCHONDRIAL FITNESS AND CELL ADHESION/MIGRATION IN DIFFUSE MIDLINE GLIOMA (DMG)